Grünenthal Meds
Sean Tighe currently serves as Associate Director - Corporate Planning at Grünenthal Meds, a position held since July 2023, and has also taken on roles including Project Manager and Regulatory Affairs Manager. Prior to this, Sean Tighe worked at Kyowa Kirin International plc. from September 2015 to June 2023, progressing through several roles in regulatory affairs, culminating as Regulatory Affairs Manager. Sean Tighe's educational background includes a Bachelor's Degree in Human Physiology from the University of Leeds, attended from 2011 to 2015, and prior studies at Oldham Sixth Form College and Hollingworth Business and Enterprise College. Sean Tighe also gained experience as a Global Regulatory Assistant at RB from July 2013 to July 2014.
This person is not in any teams
This person is not in any offices
Grünenthal Meds
1 followers
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.